Cutter & CO Brokerage, Inc. Axcella Health Inc. Transaction History

Cutter & CO Brokerage, Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	SELL	$1.58 - $2.82 $10,270 - $18,330	-6,500 Reduced 24.71%	19,800 $51,000
Q4 2021 Feb 10, 2022	SELL	$2.06 - $3.61 $18,540 - $32,490	-9,000 Reduced 25.5%	26,300 $55,000
Q2 2021 Aug 09, 2021	BUY	$3.08 - $5.13 $108,724 - $181,089	35,300 New	35,300 $142,000

61.6K

Ticker AXLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 73,500,896
Description
Axcella Health Inc. operates as a clinical stage biotechnology company in the United States. The company treats complex diseases and enhances health using endogenous metabolic modulator compositions. Its lead product candidates include AXA1665, which is in Phase 2 clinical trial for the reduction in risk of overt hepatic encephalopathy recurrenc...

Get notified when there are updates to the investment portfolio of Cutter & CO Brokerage, Inc., based on Form 13F filings with the SEC.

Stay updated on Cutter & CO Brokerage, Inc. with notifications on news.